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Abstract
Background: Degenerative changes of lumbar spine anatomy resulting in the encroachment of neural structures
are often regarded progressive, ultimately necessitating decompressive surgery. However the natural course is not
necessarily progressive and the efficacy of a variety of nonsurgical interventions has also been described. At
present there is insufficient data to compare surgical and nonsurgical interventions in terms of their relative benefit
and safety. Previous attempts failed to provide clear clinical recommendations or to distinguish subgroups that
substantially benefit from a certain treatment strategy. We present the design of a randomized controlled trial on
(cost-) effectiveness of surgical decompression versus prolonged conservative treatment in patients with
neurogenic intermittent claudication caused by lumbar stenosis.
Methods/Design: The aim of the Verbiest trial is to evaluate the effectiveness of prolonged conservative treatment
compared to decompressive surgery. The study is a multi-center randomized controlled trial with two parallel
groups design. Patients (age over 50) presenting to the neurologist or neurosurgeon with at least 3 months
complaints of neurogenic intermittent claudication and considering surgical treatment are eligible for inclusion.
Participants are randomly allocated to either prolonged conservative treatment, receiving further treatment from
their general practitioner and physical therapist, or allocated to surgery and operated within 4 weeks. Primary
outcome measure is the functional assessment of the patient as measured by the Zurich Claudication
Questionnaire at 24 months of follow-up. Data is analyzed according to the intention to treat principle.
Discussion: With a cost-effectiveness analysis the trade off between the costs of prolonged conservative treatment
and delayed surgery in a smaller number of patients are compared with the current policy of surgical
management. As surgery is expected to be inevitable in certain subgroups of patients, the distinction of and
classification by predictive patient characteristics is most relevant to clinical practice.
Trial registration: Netherlands Trial Register (NTR): NTR2216
Background
Lumbar stenosis is defined as a reduction in the diameter
of the spinal canal, lateral nerve canals, or neural fora-
mina. Most frequently lumbar stenosis is the result of a
degenerative disease process and consequently involves
multiple levels of the lumbar spine or sites of lumbar ste-
nosis. Degenerative lumbar stenosis is caused by bone
hypertrophy, osteoarthritis of facet joints, ligamentous
hypertrophy, disc protrusion, spondylolisthesis alone or
any combination of these elements. Central canal stenosis
results in compression of the cauda equina. Lateral recess
stenosis and neuro foraminal stenosis result in encroach-
ment of the nerve root. Degenerative spinal stenosis most
commonly affects the L3-L4, and L4-L5 segments to
cause cauda equina compression [1,2].
Symptoms related to lumbar stenosis range from
numbness, fatigue to actual pain of the buttocks, thighs,
and legs. Back pain and muscle weakness are also
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frequently reported. Symptoms may radiate from the
buttocks to the distal lower extremities and are often
accompanied with paraesthesias. In contrast to sciatica
symptoms are generally bilateral and localized poorly
[2]. A pathognomonic aspect of lumbar stenosis is the
relation between symptoms and function. Symptoms are
typically aggravated by standing and walking. However
symptoms generally decrease with sitting or standing
with lumbar flexion and with lying. As symptoms wor-
sen patients become progressively limited in their activ-
ities and walking distance. This relationship is known as
neurogenic intermittent claudication [3]. The clinical
entity was first described by the Dutch neurosurgeon
Verbiest in 1950, thus formerly also referred to as the
Verbiest syndrome [4].
Degenerative lumbar stenosis is the most common
reason for lumbar surgery in elderly people [5]. Taking
into account that the mean age of the total population
of the Netherlands and other Western countries will
increase over the upcoming years and due to an increas-
ing life expectancy in general, surgery rates are expected
to increase even further. However the aging of the
population does not explain the total increase of lumbar
surgery rates observed over the past decades. Also there
are significant geographic variations in spine surgery
rates [5-7]. Despite extensive research in this area, var-
ious authors suggest a poor consensus on indications
for surgery or the choice of particular surgical proce-
dures. Patient demographic and clinical characteristics
may be outweighed by surgeons and patients prefer-
ences concerning treatment allocation [5-8].
Although the condition is frequently diagnosed and
various surgical and nonsurgical interventions for indivi-
duals with neurogenic intermittent claudication are
widely accepted in clinical practice, there is limited evi-
dence to support many of them, especially in terms of
their relative benefit and risk compared with other
options [9-11]. The long-term results of surgical man-
agement of spinal stenosis are good or excellent in
50-79% of patients [9]. Most cases of spinal stenosis can
be treated with surgical decompression alone. In a
minority of cases spinal stenosis is accompanied with a
spinal deformity such as severe spondylolisthesis or sco-
liosis. In these instances the addition of spinal fusion to
decompression may be necessary to maintain spinal sta-
bility and effectively decompress neural structures [9].
The available evidence suggests no advantage in routi-
nely applying fusion techniques [11].
In a randomized controlled trial (RCT) comparing the
effectiveness of early surgery to prolonged conservative
treatment among patients with sciatica, early surgery
favored a better short-term outcome compared to pro-
longed conservative management [12]. However, there
was no significant nor clinically relevant difference
between treatment groups after 1 year. It is well known
that the natural history of sciatica caused by lumbar
disk herniation is favorable in most cases [13]. Sponta-
neous involution of herniated disk material can also be
observed with imaging studies [14]. By contrast lumbar
stenosis is caused by long-term degenerative changes
affecting the structures surrounding the cauda equine or
nerve roots. Unlike disc herniation these degenerative
changes are not likely to resolve spontaneously. How-
ever the extent of narrowing of the central or lateral
canal is not necessarily associated with symptom sever-
ity [2]. In addition, imaging studies demonstrate radiolo-
gical significant lumbar stenosis can be found in up to
20 percent of asymptomatic elderly individuals [15,16].
Various studies observing the natural course of neuro-
genic intermittent claudication report improvement of
symptoms and conclude that expectant observation
could be an alternative to surgical treatment [9,17-21]. In
a review by Watters et al. the effectiveness of nonsurgical
therapy is discussed [9]. Favorable outcomes are achieved
in approximately 70% of patients with moderate symp-
toms and in 33% with severe symptoms. Approximately
20-40% of patients with moderate symptoms who are
treated conservatively require surgery in the long-term
(2-10 years). However, overall observational results of
surgical treatment consistently demonstrate better short-
term and long-term results when compared to conserva-
tive therapy. Consequently, and despite the apparent
superiority of surgical treatment, nonsurgical treatment
can be an effective therapy in selected patients. Further-
more surgical intervention is equally effective when per-
formed after failure of conservative treatment compared
to primary surgical management [17].
Limited evidence is available regarding the efficacy for
nonsurgical treatments in the treatment of lumbar steno-
sis [9,10]. Nonsurgical treatments have most frequently
been compared to other treatments, rather than to the
natural course of lumbar stenosis. Currently the choice
of treatment is guided mainly by clinical judgment,
observational studies and in analogy to other back condi-
tions. A systematic review assessing the effectiveness of
nonsurgical treatment of nonspecific low back pain sug-
gests efficacy for a variety of nonsurgical interventions
[10]. Treatment should focus on patient education, medi-
cations to control pain and exercise therapy [10,22].
Two previous RCTs comparing the effectiveness of sur-
gery to nonsurgical treatment of degenerative lumbar ste-
nosis have been performed [23,24]. Weinstein et al.
reported favorable results for surgery throughout the 2
year follow-up period [23]. However the design of the trial
was compromised due to large cross-over rates among
both treatment groups, at least if one wants to estimate
the true magnitude of the effect of surgery compared to
nonsurgical treatment. Cross-over to some extent is to be
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expected, as a subgroup of patients will have complaints
refractory to nonsurgical management. However there was
also considerable nonadherence among subjects allocated
to surgery; only 67% of the surgical group underwent sur-
gery during the two years of follow-up and non-adherence
was even larger at earlier time points (54% at 6 months
and 42% at 3 months). Possibly subjects reported signifi-
cant symptom relief before surgery had been scheduled.
More likely, however, these subjects did not have symp-
toms severe enough to justify surgical treatment or did
not yet consider surgery as treatment. To address treat-
ment nonadherence conclusions were based on an as trea-
ted analysis rather than an intention to treat analysis.
These results must be interpreted cautiously as confound-
ing is no longer controlled by random allocation. Although
the analysis was corrected for known confounding factors,
baseline comparability for other factors can not be
assured. Further, the validity of conclusions is limited due
to a patient selection bias since post-randomization elig-
ibility for surgery in the initially conservative group and
vice versa is clearly correlated to the condition of the
patient prior to the cross-over. Malmivaara et al. and also
reported favorable results for surgery as compared to con-
servative treatment [24]. Based on a previously defined
minimal clinically imported difference (MCID) with regard
to functional disability 63% of surgically managed subjects
reported improvement compared to 30% of conservatively
managed subjects [25]. In concordance with previous stu-
dies the initial advantage of surgery over conservative
management was followed by a narrowing of the relative
benefit over time [18,26]. Apart from the relatively small
sample size, only subjects with moderate symptom severity
were included. Final conclusions were further limited by
the heterogeneity of treatments as surgical decompression
was accompanied by fusion techniques in 20% of the sub-
jects allocated to surgery. The distinction of surgical can-
didates in both RCT deserves scrutiny, especially since the
generalizability of the findings depends on the ability of
the study design to reflect the current clinical challenge.
At present there is still a paucity of high quality evi-
dence to justify the timing of surgery and useful clinical
parameters to identify subjects for the most appropriate
treatment strategy are lacking. The primary goal of this
study is to assess the (cost-) effectiveness of a policy of
conventional surgical intervention as compared to pro-
longed conservative management in the treatment of
degenerative lumbar stenosis. Further, patient character-
istics and clinical findings are evaluated to define sub-
groups that substantially benefit from one of the two
proposed treatment strategies.
Methods and design
The study is designed as a multi-center RCT with two
parallel groups. The multi-center design is necessary to
accrue the required amount of patients and obtain gener-
alizable results. The trial is conducted in the hospitals,
which previously collaborated in the Sciatica trial [12].
The medical research ethics committee of each hospital
has approved the trial. If inclusion and exclusion criteria
are met, patients are asked to participate in the proposed
trial. Patients are randomized if the diagnosis lumbar ste-
nosis is confirmed by imaging findings and an indication
for surgery is confirmed by the neurosurgeon. Partici-
pants are allocated to either prolonged conservative treat-
ment or surgery. As national consensus guidelines for the
nonsurgical treatment of lumbar stenosis are lacking a
clinical treatment protocol was developed for this trial.
The purpose of such a protocol is to provide comparable
nonsurgical treatment throughout the participants and
aid adherence to treatment allocation. Surgery is sched-
uled within 4 weeks after randomization. As the clinical
investigator and the research nurse offer counseling and
evaluate possible negative health effects of treatment allo-
cation, they cannot be blinded for randomization out-
come. Throughout the study period participants fill out
questionnaires and physical examination findings are
recorded during consecutive visits to the outpatient
clinic. The follow-up period will last 5 years. After six
months secondary surgery is offered in case prolonged
conservative treatment does not result in satisfactory
symptom relief or functional improvement.
Participants and recruitment
Patients presenting to the neurologist or neurosurgeon
in the participating hospitals with at least 3 months
complaints of neurogenic intermittent claudication and
considering surgical treatment are eligible for inclusion.
The duration of these complaints is one of the main (a
priori defined) factors to be evaluated for a possible
treatment-effect-modification. Inclusion and exclusion
criteria are listed in Table 1.
General practitioners and physical therapists in the
vicinity of the participating hospitals have been
informed at the start of the trial. They are directly
involved as they provide primary care for subjects allo-
cated to prolonged conservative treatment. Secondly,
general practitioners are asked to refer potentially eligi-
ble patients with neurogenic intermittent claudication to
the outpatient clinics for evaluation by the neurologist.
Prolonged conservative management
Conservative management is a prolonged nonsurgical
treatment policy conducted by the general practitioner.
The general practitioner provides additional information
about the condition’s causes, symptoms and treatment
options. Further, the efficacy of the prescribed pain medi-
cation is reviewed and if necessary alterations are made,
taking into account possible contra-indications in the
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elderly. Subjects are advised to stay active and if possible
return to work and/or their leisure activities. The general
practitioner prescribes physical therapy, which consists of
active exercises to guide the patient in upgrading his or
her activities according to an agreed time schedule. The
guide is time, not the intensity of the pain. The protocol
for the individual exercise therapy supervised by a physical
therapist includes education, stretching, strengthening and
conditioning exercises [27]. Education in proper posture,
body mechanics for daily activities, and if necessary, the
use of orthopedic aids is essential to maintain the gains
made through the physical therapy sessions. The goal of
stretching and strengthening is to decrease the extension
forces on the lumbar spine attributable to agonist muscle
tightness, antagonist weakness or both, which results in a
decreased lumbar lordosis. Stretching exercises include
hip flexor stretching, hamstring stretching and lumbar
paraspinal stretching. The strengthening exercises primar-
ily target the abdominal and lower extremity muscles. The
conditioning exercises include walking on a treadmill, on
level and inclined surfaces and/or riding a stationary
bicycle, with the goal of increasing general fitness. A maxi-
mum of 9 sessions is allowed in the first 3 months. Three
additional booster sessions take place in the fourth, fifth,
and sixth month [10]. A physical therapy session in
primary care lasts about 30 minutes. The exercise therapy
is discontinued if, according to the physical therapist,
treatment goals have been achieved.
Surgical management
After induction of general endotracheal anaesthesia the
patient is positioned prone or in knee-chest position.
The level on which to operate is determined through
anatomical landmarks and confirmed by fluoroscopy.
After a midline posterior skin and subcutaneous tissue
incision centered at the interspinous level to be decom-
pressed, the dissection goes through the dorsolumbar
fascia. The multifidi are detached from both sides of the
spinous processes and laminar attachments. Paraspinal
muscles are than retracted laterally. The interspinous
ligament is resected to enable the removal of the inferior
aspect of the cranial lamina and the superior aspect of
the caudal lamina. Subsequent a flavectomy is per-
formed. The decompression is extended laterally with
an undercutting of the medial aspect of the facet joints
and if necessary an extensive foraminotomy is per-
formed. In case of severe bony stenosis a complete lami-
nectomy is performed. No transpedicular fixation of the
spine is performed during the first surgery. Hospital
admission is 2 to 4 days, including the day of surgery.
During the post-operative period the patients are mobi-
lized accompanied by a physical therapist, starting 3
hours after surgery. If the patient regains the physical
ability to manage basis activities of daily living, the
patient is discharged. At home the patients visit their
own physical therapist who guides them and provides
exercises. If possible patients gradually resume their
daily activities and work if applicable. The patient is
allowed to resume all activities in case no physical lim-
itations are present.
Study measurements
Clinical data is collected during consecutive follow-up
visits to the outpatient clinics at baseline and at 12, 26,
52, 104, 260 weeks after randomization. Subjects fill in
questionnaires at selected time points which are
returned during the outpatient clinic visits or by mail
(Table 2). Demographic data, physical examination find-
ings information on pain intensity, imaging findings, ill-
ness related disability, societal costs and utilities and
quality of life are collected. Further, subjects keep a
diary on the financial consequences and health care
consumption related to lumbar stenosis. Visits to the
general practitioner, physical therapist, medical specia-
lists, alternative health practice, use of analgesics, dura-
tion of sick leave from work and additional utility/
mobility costs are recorded. The patient diaries are
returned to the research nurse during the outpatient
clinic visits or by mail.
Table 1 Inclusion and exclusion criteria
Inclusion
criteria
- Age ≥50 years old
- ≥3 Months neurogenic intermittent claudication, as
noted by leg/buttock/groin pain with or without back
pain or fatigue in the legs provoked by walking. Leg/
buttock/groin pain or fatigue needs to be relieved by
lumbar flexion
- Narrowed lumbar spinal canal, nerve root canal or
intervertebral foramen at one or more levels confirmed
by MRI
- Regular indication for surgical decompression
- Signed informed consent
Exclusion
criteria
- Cauda equine syndrome
- Paget’s disease, severe osteoporosis or metastasis to
the vertebrae
- Significant scoliosis (Cobb angle > 25 degrees)
- Previously laminectomy at the same level, has
degenerative or lytic spondylolisthesis ≥ grade 2 (on a
scale 1 to 4) at the affected level or significant
instability of the lumbar spine
- Severe comorbid conditions that increase the risk to
the patient or interfere with the evaluability of this
study (e.g. severe ischemic heart disease,
musculoskeletal or neurological conditions impairing
walking ability, cognitive impairment (MMSE <25
points)
- Unable to read or write Dutch
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Primary outcome measure
Zurich Claudication Questionnaire (ZCQ)
The ZCQ is a validated disorder-specific outcome
measure specifically designed for lumbar spinal steno-
sis [28,29]. The questionnaire consists of 3 scales: a
symptom severity scale, a physical performance scale
and a patient satisfaction scale. Multiple validated
questionnaires exist for the use in evaluating back con-
ditions, however the ZCQ specifically addresses the
symptoms and functional deficits associated with spinal
stenosis. Further, this questionnaire provides additional
information on patient’s satisfactory with the results of
surgery.
Secondary outcome measures
Shuttle Walking Test (SWT)
The functional status of the patient can be assessed by
the SWT. The SWT has previously been used as an out-
come measure in the evaluation of patients with neuro-
genic intermittent claudication [29]. Subjects are
required to walk back and forth, turning around two
cones placed 9 meters apart making the shuttle distance
10 meters long. The distance travelled during 15 minutes
and/or the time until neurogenic intermittent claudica-
tion prohibits further walking is recorded.
Mobility examination
Allocation to prolonged conservative treatment may
possibly result in subjects becoming less active. As the
activity level decreases, situations as walking/standing
that give rise to symptoms of neurogenic intermittent
claudication diminish and possibly result in symptom/
pain relief. Although physical activity, disability and
symptom severity are assessed during follow-up exami-
nations, typically the reliability and validity of the mea-
surement of habitual physical activity by questionnaires
is low [30]. A continuous 7-day measurement with triax-
ial accelerometers (GENEA®, Unilever) provides infor-
mation about the total amount, the frequency, the
intensity, and the duration of physical activity [31-33].
Further, a common geriatric assessment, the Short Phy-
sical Performance Battery (SPPB), is used to assess how
well older persons perform simple movements that
represent the building blocks of daily activities that
require good lower extremity function [34].
Roland Morris Disability Questionnaire (RMDQ)
The RMDQ is one of the most frequently used func-
tional disability questionnaires for back-related condi-
tions. The RMDQ was originally designed as a back
condition specific questionnaire but is also widely used
for patients with sciatica and neurogenic intermittent
claudication [18,35,36]. The RMDQ score ranges from 0
(no disability) to 23 (maximum disability). A validated
Dutch language version of the RMDQ is available. Com-
pared to the Oswestry disability, of which no validated
Dutch version is available, the sensitivity to change is in
favor of the RMDQ [37].
Short Form-36 (SF-36)
The SF-36 is generic health survey questionnaire that
measures overall health status, functional status and
health-related quality of life [38,39]. The questions are
divided in to eight domains: physical functioning, physi-
cal role limitations, emotional role limitations, social
functioning, physical pain, general mental health, vitality,
general health perception. For each domain, item scores
are coded, summed, and transformed on to a scale from
0 (worst health) to 100 (best health).
Perceived Recovery
Perceived recovery is assessed with a seven-point likert
scale varying from ‘completely recovered’ to ‘worse than
ever’. The scales are completed by the patient, the
research nurse and the neurosurgeon.
Visual analogue scale (VAS) for pain in back and leg
The pain intensity experienced by the patient during the
past week is assessed on a horizontal 100 millimeters
scale varying from 0 millimeter, “no pain”, to 100 milli-
meters ‘the worst pain I can imagine’ [40,41]. Back and
leg pain is assessed separately.
Table 2 Study measurements over time
Time in weeks -2 0 4 12 26 38 52 104 156 208 260
Inpatient visit:
surgery
x
Outpatient visit x x x x x x x
Questionnaire x x x x x x x x x x
Patient
demographics
x
MMSE x
Basic physical
examination
x
Neurological
examination
x x x x x x
X-ray x x
MRI x
ZCQ x x x x x x x x x x
Shuttle Walking Test x x x x x
Accelerometry x x x x x
SPPB x x x x x x
RMDQ x x x x x x x x x x
SF-36 x x x x x x x x x x
Perceived Recovery x x x x x x x x x
VAS for legs and
back
x x x x x x x x x x
EuroQol-5D x x x x x x x x x x
Patient diary x x x x x x x
Complications x x x x x x
Re-operation x x x x x x
MMSE: mini-mental state examination; ZCQ: Zurich claudication questionnaire;
SPPB: short physical performance battery; RMDQ: Roland Morris disability
questionnaire; SF-36: short form 36; VAS: visual analogue scale.
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Societal costs and utilities
Cost-effectiveness is expressed as cost per QALY, based
on the QALY difference between the surgery and pro-
longed conservative treatment group. QALYs are esti-
mated by using mean health state values during
consecutive follow-up assessments with the EuroQol-5
D. The EuroQol-5 D is a generic health related quality
of life questionnaire frequently used for investigating
cost-effectiveness [42,43]. Treatment costs and direct
medical costs are estimated on basis of the cost centre
method. Participants are requested to record direct
medical costs (e.g. physiotherapy, visits to general practi-
tioners and medical specialists, nursing care, and medi-
cation) and indirect cost (e.g. disability related loss of
productivity and additional travel expenses) using a cost
diary.
Complications and re-operation incidence
The neurosurgeon and research nurse systematically
record direct and indirect surgical complications and re-
operation incidence. In case of failure of prolonged con-
servative management considerations for delayed surgery
are reviewed.
Sample size
The success rate of both treatments is determined
through perceived recovery and by applying the concept
of MCID on the self reported functional disability
scores. Derived from previous studies the estimated suc-
cess rate of surgical management is 60% [9,24,44] and
conservative management 40% [9,18,20,24] at 2 years of
follow-up. The sample size calculation is based on the
comparison of two independent proportions and con-
tains the following parameters: Alpha: 0.05 (2-sided),
Beta: 0.10 (90% power), success rate surgery: 0.6, success
rate prolonged conservative treatment: 0.4. These
assumptions yield a required sample size of 260 patients.
Based on an expected drop-out rate of around 10% 280
patients need to be accrued (i.e. 140 patients in each
treatment group). A sample size calculation based on
the RMDQ yields approximately the same result. A dif-
ference of 3 points has been recommended for sample
size calculations for clinical trials [36,45]. With Alpha:
0.05, Beta 0.10, μ difference of 3, and a standard devia-
tion of RMDQ scores of 7.6 [18,36] a sample size of 270
patients is required.
Statistical analysis
Differences between treatment groups at baseline are
assessed using univariate analyses to check for a
balanced randomization. In case of substantial differ-
ences that induce confounding of the main treatment
effect, both an uncorrected and a corrected (multivari-
ate) analysis are presented. Data analysis is performed
according to the intention to treat principle. The
primary hypothesis using the primary outcome measure
is a comparison of the average ZCQ over a period of
24 months. All continuous outcome measures are
assessed with a repeated-measures analysis of variance
with a first-order autoregressive covariance matrix.
Differences between treatment groups are assessed by
computing both the main effect of the treatment and
the interaction between treatment and time in a mixed
linear model. The area under curve for the ZCQ scores
and secondary treatment outcome variables during the
follow-up period are compared both implicitly using the
repeated measurements approach. A Kaplan-Meier sur-
vival analysis is used to estimate the proportion of
patients reporting recovery as a function of time elapsed
from randomization. The average difference is charac-
terized by a Hazard Ratio derived from a Cox Propor-
tional Hazards model and the accompanying likelihood
ratio test.
Table 3 lists the predefined patient characteristics and
clinical findings possibly related to treatment outcome.
These patient characteristics and clinical findings are
assessed in a series of multivariate models where each
particular covariate (patient characteristic or clinical
finding) is tested for treatment-effect modification by
extending the main analysis models (either the repeated
measurements models or the survival models) by the
main effect and the treatment*covariate interaction, thus
providing a formal testing framework.
One covariate is pre-specified as a primary effect-
modifier: duration of complaints at randomization. This
covariate is clinically crucial since it allows the estima-
tion of a possible “timing-of-surgery” effect by using the
natural variability among patients with respect to the
Table 3 Predefined patient characteristics and clinical
findings possibly related to treatment outcome
Patient
characteristics
- Age
- Gender
- Pain intensity
- Duration of symptoms
- Predominant symptom (back pain compared to
leg pain)
- Walking distance
- Patient’s preference for treatment
Clinical findings
- One versus multiple level stenosis
- Extent of stenosis (diameter/surface area MRI)
- Localization stenosis (lateral recess or central
canal)
- Concomitant spondylolisthesis
- Neurological impairment (muscle weakness,
sensory loss)
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duration of complaints at the moment of the decision to
perform surgery or to postpone it. Therefore each of the
main analyses is accompanied with an extension to test
for “duration-of-complaints” * “treatment” interaction.
This interaction is tested at the nominal 5% level within
the primary analysis. If the interaction is not significant,
the primary analysis of this trial defaults to the standard
model with main effects. If the interaction is significant,
it follows that a fortiori a treatment effect exists (and it
varies with the duration of complaints). The model with-
out the interaction still gives the overall (average) effect
of the main hypothesis with its associated confidence
interval. For the remaining 11 variables in Table 3 a 10%
level of significance is applied, due to the reduced power
of these tests. First two models are fitted, one with all
patient characteristics and their interactions, and one
with all clinical factors and their interactions. The total
model improvement by adding the set of interactions is
tested with the appropriate degrees of freedom. Hence 2
statistical tests are performed and a Bonferroni correc-
tion to the alpha level of 5% is applied to test whether
any characteristic or clinical finding exists which modifies
the treatment effect. When significance in one or both
models exists, each individual covariate is tested, using a
Bonferroni-Holm correction based on the number of
covariates in the respective collection of covariates. Any
such factor eventually classified as a significant effect
modifier (Bonferroni-Holm with 10% as a starting level
of significance) leads to subgroup estimation of treatment
effects, to be tabulated in the final analysis.
Data is stored via the internet-based secure data man-
agement system “ProMISe” of the department of Medi-
cal Statistics and Bio Informatics. The analyses are
carried out using appropriate statistical software (e.g.
SAS, SPSS).
Discussion
It has been previously suggested that conservative man-
agement should be the initial treatment of degenerative
lumbar stenosis and decompressive surgery is appropriate
to consider only in case of intolerable pain or disability.
Despite these recommendations the overall observed
clinical improvement after surgery is disappointing and a
substantial proportion of surgical candidates managed
conservatively may still report improvement. Taken in to
account the unexplained large geographic variation of
surgery rates for lumbar stenosis and the long-term nar-
rowing of the relative benefit of surgery compared to
conservative management, another critical appraisal of
indications for surgery is necessary.
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